A significant difference between the arms favoring ETV was reached as early as Day 10. At 12 weeks, 52% (17/33) of ETV patients had HBV DNA below 10 000 copies/ml compared to 25% (8/32) for ADV patients.
英
美
- 2個(gè)治療組病毒下降的差異在第10天就體現出來(lái),ETV治療組病毒下降更低,2組間有顯著(zhù)差異。 12周時(shí),52%25(17/33)ETV治療患者HBV DNA低于10000 copies/ml,而ADV組為25%25(8/32)。